Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 286-296 , December 2006

The Child with Cerebral Palsy: Diagnosis and Beyond

  • Ellen Wood, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Ellen Wood, MD, IWK Health Centre, Dalhousie University, 5850-5980 University Ave, Halifax, NS, Canada B3K 6R8, 902-470-8477.

References 

  1. Mutch L, Alberman E, Hagberg B, et al. Cerebral palsy epidemiology: Where are we now and where are we going?. Dev Med Child Neurol. 1992;34:547–551
  2. Gupta R, Appleton RE. Cerebral palsy: Not always what it seems. Arch Dis Child. 2001;85:356–360
  3. Nelson KB, Ellenberg JH. Children who “outgrew” cerebral palsy. Pediatrics. 1982;69:529–536
  4. Kuban KCK, Leviton A. Cerebral palsy. N Enlg J Med. 1994;330:188–195
  5. Keogh JM, Badawi N. The origins of cerebral palsy. Curr Opin Neurol. 2006;19:129–134
  6. Ancel P-Y, Livinec F, Larroque B, et al. Cerebral palsy among very preterm children in relation to gestation age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrcs. 2006;117:828–835
  7. O’Shea TM, Counsell SJ, Bartels DB, et al. Magnetic resonance and ultrasound brain imaging in preterm infants. Early Hum Dev. 2005;81:263–271
  8. Mirmiran M, Barnes PD, Keller K, et al. Neonatal brain magnetic resonance imaging before discharge is better than serial cranial ultrasound in predicting cerebral palsy in very low birth weight preterm infants. Pediatrics. 2004;114:992–998
  9. Maruyama K, Okumura A, Hayakawa F, et al. Prognostic value of EEG depression in preterm infants for later development of cerebral palsy. Neuropediatrics. 2002;33:133–137
  10. Hoyert DL, Mathews TJ, Menacker F, et al. Annual summary of vital statistics:2004. Pediatrics. 2006;117:168–183
  11. Wilson-Costello D, Friedman H, Minich N, et al. Improved survival rates wth increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005;115:997–1003
  12. Marlow N, Wolke D, Bracewell MA, et al. EPICure Study Group Neurologic and developmental disability at six years of age after extremely preterm birth. N Enlg J Med. 2005;352:9–19
  13. Shevell MI. The “Bermuda triangle” of neonatal neurology: Cerebral palsy, neonatal encephalopathy and intrapartum asphyxia. Semin Pediatr Neurol. 2004;11:24–30
  14. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress (A clinical and electroencephalographic study). Arch Neurol. 1976;33:696–705
  15. Ellenberg JH, Nelson KB. Cluster of perinatal events identifying infants at high risk for death or disability. J Pediatr. 1988;113:546–552
  16. Shevell MI, Majnemer A, Morin I. Etiologic yield of cerebral palsy: A contempory case series. Pediatr Neurol. 2003;28:352–359
  17. Badawi N, Felix JF, Kurinczuk JJ, et al. Cerebral palsy following term newborn encephalopathy. Dev Med Child Neurol. 2005;47:293–298
  18. Selton D, Andre M. Prognosis of hypoxic-ischemic encephalopathy in full-term newborns—Value of neonatal encephalography. Neuropediatrics. 1997;28:276–280
  19. van Rooij LGM, Toet MC, Osredkar D, et al. Recovery of amplitude integrated electroencephalographic background patterns within 24 hours of perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed. 2005;90:F245–F251
  20. Barkovich AJ, Westmark K, Partridge C, et al. Perinatal asphyxia: MR findings in the first 10 days. AJNR Am J Neuroradiol. 1995;16:427–438
  21. Barkovich AJ, Baranski K, Vigneron D, et al. Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates. AJNR Am J Neuroradiol. 1999;20:1399–1405
  22. L’Abee C, de Vries LS, van der Grond J. Early diffusion-weighted MRI and H-magnetic resonance spectroscopy in asphyxiated full-term neonates. Biol Neonate. 2005;88:306–312
  23. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004;3:150–158
  24. Sreenan C, Bhargava R, Robertson CM. Cerebral infarction in the term newborn: Clinical presentation and long-term outcome. J Pediatr. 2000;137:351–355
  25. Wu YW, March WM, Croen LA, et al. Perinatal stroke in children with motor impairment: A population-based study. J Pediatr. 2004;114:612–619
  26. Lee J, Croen LA, Backstrand KH, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA. 2005;293:723–729
  27. Nelson KB, Dambrosia JM, Grether JK, et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol. 1998;44:665–675
  28. Mercuri E, Cowan F, Gupte G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001;107:1400–1404
  29. Reid S, Halliday J, Ditchfield M, et al. Factor V Leiden mutation: a contributory factor for cerebral palsy. Dev Med Child Neurol. 2006;48:14–19
  30. Cans C, McManus V, Crowley M, et al. Cerebral palsy of post-neonatal origin: Characteristics and risk factors. Paediatr Perinat Epidemiol. 2004;18:214–220
  31. Rademaker KJ, Uiterwaal CSPM, Beek FJA, et al. Neonatal cranial ultrasound versus MRI and neurodevelopmental outcome at school age in children born preterm. Arch Dis Child Fetal Neonatal Ed. 2005;90:F489–F493
  32. Candy EJ, Hoon AH, Capute AJ, et al. MRI in motor delay: Important adjunct to classification of cerebral palsy. Pediatr Neurol. 1993;9:421–429
  33. Serdaroglu G, Tekgul H, Kitis O, et al. Correlative value of magnetic resonance imaging for neurodevelopmental outcome in periventricular leukomalacia. Dev Med Child Neurol. 2004;46:733–739
  34. Cans C, Surman G, McManus V, et al. Cerebral palsy registries. Semin Pediatr Neurol. 2004;11:18–23
  35. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005;47:571–576
  36. Wichers MJ, Odding E, Stam HJ, et al. Clinical presentation, associated disorders and aetiological moments in cerebral palsy: A Dutch population-based study. Disabil Rehabil. 2005;27:583–589
  37. Pharoah POD, Cooke T, Johnson MA, et al. Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed. 1998;79:F21–F25
  38. Rosenbaum P. Cerebral palsy: What parents and doctors want to know. BMJ. 2003;326:970–974
  39. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–223
  40. Palisano RJ, Tieman BL, Walter SD, et al. Effect of environmental setting on mobility methods of children with cerebral palsy. Dev Med Child Neurol. 2003;45:113–120
  41. Gorter JW, Rosenbaum PL, Hanna SE, et al. Limb distribution, motor impairment, and functional classification of cerebral palsy. Dev Med Child Neurol. 2004;46:461–467
  42. Porro G, van der Linden D, van Nieuwenhuizen O, et al. Role of visual dysfunction in ostural control in children with cerebral palsy. Neural Plast. 2005;12:205–210
  43. Wood E, Rosenbaum P. The Gross Motor Function Classification System for cerebral palsy: A study of reliability and stability over time. Dev Med Child Neurol. 2000;42:292–296
  44. Rosenbaum PL, Walter SD, Hanna SE, et al. Prognosis for gross motor function in cerebral palsy. JAMA. 2002;288:1357–1363
  45. Law M, Hanna S, King G, et al. Factors affecting family-centered service delivery for children with disabilities. Child Care Health Dev. 2003;29:357–366
  46. King GA, Rosenbaum PL, King SM. Evaluating family-centered service using a measure of parents’ perceptions. Child Care Health Dev. 1997;23:47–62
  47. King S, Teplicky R, King G, et al. Family-centered service for children with cerebral palsy and their families: A review of the literature. Semin Pediatr Neurol. 2004;11:78–86
  48. Raina P, O’Donnell M, Rosenbaum P, et al. The health and well-being of caregivers of children with cerebral palsy. Pediatrics. 2005;115:626–636
  49. Clopton N, Dutton J, Featherston T, et al. Interrater and intrarater reliability of the Modified Ashworth Scale in children with hypertonia. Pediatr Phys Ther. 2005;17:268–274
  50. Thompson AJ, Jarrett L, Lockley L, et al. Clinical management of spasticity. J Neurol Neurosurg Psychiatry. 2005;76:459–463
  51. Tilton AH. Therapeutic interventions for tone abnormalities in cerebral palsy. NeuroRx. 2006;3:217–224
  52. Koman LA, Mooney JF, Smith B, et al. Management of cerebral palsy with botulium-A toxin: Preliminary investigation. J Pediatr Orthop. 1993;13:489–495
  53. Baker R, Jasinski M, Maciag-Tymecka I, et al. Botulium toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled dose-ranging study. Dev Med Child Neurol. 2002;44:666–675
  54. Reddihough DS, King JA, Coleman GJ, et al. Functional outcome of botulium toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol. 2002;44:820–827
  55. Glanzman AM, Kim H, Swaminathan K, et al. Efficacy of botulium toxin A, serial casting, and combined treatment for spastic equines: A retrospective analysis. Dev Med Child Neurol. 2004;46:807–811
  56. Kay RM, Rethlefsen SA, Fern-Buneo A, et al. Botulium toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am. 2004;86A:2377–2384
  57. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulium toxin A with casting for treatment of dynamic equines in children with cerebral palsy. Dev Med Child Neurol. 2005;47:620–627
  58. Bottos M, Benedetti MG, Salucci P, et al. Botulium toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment. Dev Med Child Neurol. 2003;45:758–762
  59. Fehlings D, Rang M, Glazier J, et al. An evaluation of botulium-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 2000;137:300–303
  60. Speth LA, Leffers P, Janssen-Potten YJ, et al. Botulium toxin A and upper limb functional skills in hemiparetic cerebral palsy: A randomized trial in children receiving intensive therapy. Dev Med Child Neurol. 2005;47:468–473
  61. Hurst DL, Lajara-Nanson WA, Lance-Fish ME. Walking with modafinil and its use in diplegic cerebral palsy: retrospective review. J Child Neurol. 2006;21:294–297
  62. Krach LE, Kriel RL, Gilmartin RC, et al. GMFM 1 year after continuous intrathecal baclofen infusion. Pediatr Rehabil. 2005;8:207–213
  63. Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg. 1997;27:40–44
  64. Buonaguro V, Scelsa B, Curci D, et al. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol. 2005;33:110–113
  65. Darbari FP, Melvin JJ, Piatt JH, et al. Intrathecal baclofen overdose followed by withdrawal: Clinical and EEG features. Pediatr Neurol. 2005;33:373–377
  66. Sansone JM, Mann D, Noonan K, et al. Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop. 2006;26:125–128
  67. McLaughlin J, Bjornson K, Temkin N, et al. Selective dorsal rhizotomy: Meta-analyisis of three randomized controlled trials. Dev Med Child Neurol. 2002;44:17–25
  68. Mittal S, Farmer JP, Al-Atassi B, et al. Functional performance following selective posterior rhizotomy: Long-term results determined using a validated evaluative measure. J Neurosurg. 2002;97:510–518
  69. Steinbok P, Hicdonmez T, Sawatzky B, et al. Spinal deformities after selective dorsal rhizotomy of spastic cerebral palsy. J Neurosurg. 2005;102:S363–S373
  70. Morrell DS, Pearson JM, Sauser DD. Progressive bone and joint abnormalities of the spine and lower extremities in cerebral palsy. Radiographics. 2002;22:257–268
  71. Speigel DA, Flynn JM. Evaluation and treatment of hip dysplasia in cerebral palsy. Orthop Clin North Am. 2006;37:185–196
  72. Pidcock FS, Fish DE, Johnson-Greene D, et al. Hip migration percentage in children with cerebral palsy treated with botulium toxin type A. Arch Phys Med Rehabil. 2005;86:431–435
  73. Samson-Fang L, Fung E, Stallings VA, et al. North American Growth in Cerebral Palsy Project Relationship of nutritional status to health and societal participation in children with cerebral palsy. J Pediatr. 2002;141:637–643
  74. Kong C-K, Wong H-SS. Weight-for-height values and limb anthropometric composition of tube-fed children with quadriplegic cerebral palsy. Pediatrics. 2005;116:839–845
  75. Van der Burg JJ, Jongerius PH, Van Hulst K, et al. Drooling in children with cerebral palsy: Effect of salivary flow reduction on daily life and care. Dev Med Child Neurol. 2006;48:103–107
  76. Bachrach SJ, Walter RS, Trzcinski K. Use of glycopyrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr. 1998;37:485–490
  77. Bothwell JE, Clarke K, Dooley JM, et al. Botulium toxin A as a treatment for excessive drooling in children. Pediatr Neurol. 2002;27:18–22
  78. Edgar TS. Oral pharmacotherapy of childhood movement disorders. J Child Neurol. 2003;18:S40–S49
  79. Hoon AH, Freese PO, Reinhardt EM, et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol. 2001;25:55–58
  80. Recio MV, Hauser RA, Louis ED, et al. Chorea in a patient with cerebral palsy: Treatment with levetiracetam. Mov Disord. 2005;20:762–764
  81. Ledebt A, Becher J, Kapper J, et al. Balance training with visual feedback in children with hemiplegic cerebral palsy: Effect on stance and gait. Motor Control. 2005;9:459–968
  82. Sung I-Y, Ryu J-S, Pyun S-B, et al. Efficacy of forced-use therapy in hemiplegic cerebral palsy. Arch Phys Med Rehabil. 2005;86:2195–2198
  83. Liptak GS. Complementary and alternative therapies for cerebral palsy. Ment Retard Dev Disabil Res Rev. 2005;11:156–163
  84. Rosenbaum P. Controversial treatment of spasticity: Exploring alternative therapies for motor function in children with cerebral palsy. J Child Neurol. 2003;18:S89–S94
  85. Cotton E. The Institute for Movement Therapy and School for “Conductors,” Budapest, Hungary. Dev Med Child Neurol. 1965;7:437–446
  86. Odman P, Oberg B. Effectiveness of intensive training for children with cerebral palsy—A comparison between child and youth rehabilitation and conductive education. J Rehabil Med. 2005;37:263–270
  87. Wright FV, Boschen K, Jutai J. Exploring the comparative responsiveness of a core set of outcome measures in a school-based conductive education programme. Child Care Health Dev. 2005;31:291–302
  88. Darrah J, Watkins B, Chen L, et al. Conductive education intervention for children with cerebral palsy: An AACPDM evidence report. Dev Med Child Neurol. 2004;46:187–203
  89. Neubauer RA, James PB. Cerebral oxygenation and the recoverable brain. Neurol Res. 1998;20:S33–S36
  90. Montgomery D, Goldberg J, Amar M, et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: A pilot project. Undersea Hyperb Med. 1999;26:235–242
  91. Collet JP, Vanasse M, Marois P, et al. Hyperbaric oxygen therapy for children with cerebral palsy: A multicenter placebo controlled randomized clinical trial. Lancet. 2001;357:582–586
  92. Hardy P, Collet JP, Goldberg J, et al. Neuropsychological effects of hyperbaric oxygen therapy in cerebral palsy. Dev Med Child Neurol. 2002;44:436–446
  93. Strauss D, Shavelle R. Life expectancy of adults with cerebral palsy. Dev Med Child Neurol. 1998;40:369–375
  94. Hemming K, Hutton JL, Pharoah POD. Long-term survival for a cohort of adults with cerebral palsy. Dev Med Child Neurol. 2006;48:90–95
  95. Bottos M, Feliciangeli A, Sciuto L, et al: Functional status of adults with cerebral palsy and implications for treatment of children. Dev Med Child Neurol 43:516-528, 2110
  96. Michelsen SI, Uldall P, Kejs AMT, et al. Education and employment prospects in cerebral palsy. Dev Med Child Neurol. 2005;47:511–517
  97. Canadian Pediatric Society Adolescent Health Committee. Care of adolescents with chronic health conditions. Paediatr Child Health. 2006;11:43–48
  98. American Academy of Pediatrics. Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics. 2002;110(suppl 2):1301–1335
  99. Compendium of Pharmaceuticals ad SpecialtiesCanadian Pharmacists Association. The Canadian Drug Reference for Health Professionals. Ottawa, ON, Canada: Webcom Limited; 2006;
  100. Formulary of Drugs and Dosing Manual 2004/2005. IWK Health Centre, Halifax, NS, Canada

PII: S1071-9091(06)00132-X

doi: 10.1016/j.spen.2006.09.009

Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 286-296 , December 2006

Article Tools